Second workshop on the research on the comparative analysis of NDP

Action Programme on Essential Drugs
World Health Organization
Room M-505

Day 1, Monday, 10 June 1996

Session I: Introduction

09:00-10:00

Introductory remarks by Dr Fernando S. Antezana, ADG

Opening of the workshop by Dr Jonathan D. Quick, Director, DAP
Introduction of participants
Introduction to the workshop by Mrs Pascale Brudon, DAP

Session II: NDP Performance assessment (indicators)

10:00-16:00
Presentation by countries (15 minutes each)
Presentation by countries (15 minutes each)

16:00-17:30
Identification and discussion of key methodological problems

Day 2, Tuesday, 11 June 1996

09:00-11:00
Discussion and resolution of key methodological problems

11:00-16:30
Analysis and interpretation of the findings

16:30-17:30
Synthesis of Session II

Day 3, Wednesday, 12 June 1996

Session III: Political mapping

09:00-12:00
Presentation by countries

14:00-16:00
Discussion on similarities and differences

16:00-17:00
Plenary and synthesis of Day 3

Day 4, Thursday, 13 June 1996

Session IV:

09:00-12:30
Cross national comparison:

• relevance of the systematic cross national method which has been used in the research for assessing NDP;

• review of the hypothesis developed to explain how different strategies affect the outcomes of the policy;

• review of the explanations developed for cross national variations in NDP performance.

• formulation of national and international strategies and specific policy innovations to improve implementation of national drug policies.

14:00-16:00
Planning next steps

• time schedule for the preparation of the final reports, including methodological refinements;

• strategies for dissemination of the results, including national and international seminars and publications;

• collaboration with policy-makers and donor organizations;

• funding issues. etc.

16:00
Closing remarks